NCT07092813View on ClinicalTrials.gov

Pharmacokinetics of Sulopenem Etzadroxil Plus Probenecid in Adolescents

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Pharmacokinetics After Oral Intake
Interventions
DRUG

sulopenem etzadroxil and probenecid

single dose of 500 mg of sulopenem etzadroxil and 500 mg of probenecid given orally as a bilayer tablet.

Sponsors
All Listed Sponsors
lead

Iterum Therapeutics, International Limited

INDUSTRY